Literature DB >> 19549847

Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation.

Eirini P Papapetrou1, Mark J Tomishima, Stuart M Chambers, Yvonne Mica, Evan Reed, Jayanthi Menon, Viviane Tabar, Qianxing Mo, Lorenz Studer, Michel Sadelain.   

Abstract

Human-induced pluripotent stem cells (hiPSCs) are generated from somatic cells by ectopic expression of the 4 reprogramming factors (RFs) Oct-4, Sox2, Klf4, and c-Myc. To better define the stoichiometric requirements and dynamic expression patterns required for successful hiPSC induction, we generated 4 bicistronic lentiviral vectors encoding the 4 RFs co-expressed with discernable fluorescent proteins. Using this system, we define the optimal stoichiometry of RF expression to be highly sensitive to Oct4 dosage, and we demonstrate the impact that variations in the relative ratios of RF expression exert on the efficiency of hiPSC induction. Monitoring of expression of each individual RF in single cells during the course of reprogramming revealed that vector silencing follows acquisition of pluripotent cell markers. Pronounced lentiviral vector silencing was a characteristic of successfully reprogrammed hiPSC clones, but lack of complete silencing did not hinder hiPSC induction, maintenance, or directed differentiation. The vector system described here presents a powerful tool for mechanistic studies of reprogramming and the optimization of hiPSC generation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549847      PMCID: PMC2722286          DOI: 10.1073/pnas.0904825106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.

Authors:  Nathan C Shaner; Robert E Campbell; Paul A Steinbach; Ben N G Giepmans; Amy E Palmer; Roger Y Tsien
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

Review 2.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

3.  Generation of induced pluripotent stem cells in the absence of drug selection.

Authors:  Robert Blelloch; Monica Venere; Jonathan Yen; Miguel Ramalho-Santos
Journal:  Cell Stem Cell       Date:  2007-09-06       Impact factor: 24.633

4.  Pairs of violet-light-excited fluorochromes for flow cytometric analysis.

Authors:  M T Anderson; N Baumgarth; R P Haugland; R M Gerstein; T Tjioe; L A Herzenberg; L A Herzenberg
Journal:  Cytometry       Date:  1998-12-01

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

8.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

9.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells.

Authors:  Kiichi Watanabe; Morio Ueno; Daisuke Kamiya; Ayaka Nishiyama; Michiru Matsumura; Takafumi Wataya; Jun B Takahashi; Satomi Nishikawa; Shin-ichi Nishikawa; Keiko Muguruma; Yoshiki Sasai
Journal:  Nat Biotechnol       Date:  2007-05-27       Impact factor: 54.908

View more
  138 in total

Review 1.  miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells.

Authors:  Nils Pfaff; Thomas Moritz; Thomas Thum; Tobias Cantz
Journal:  J Mol Med (Berl)       Date:  2012-06-09       Impact factor: 4.599

Review 2.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

3.  Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.

Authors:  Faith A Bazley; Cyndi F Liu; Xuan Yuan; Haiping Hao; Angelo H All; Alejandro De Los Angeles; Elias T Zambidis; John D Gearhart; Candace L Kerr
Journal:  Stem Cells Dev       Date:  2015-08-10       Impact factor: 3.272

4.  Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.

Authors:  Eirini P Papapetrou; Michel Sadelain
Journal:  Nat Protoc       Date:  2011-08-04       Impact factor: 13.491

5.  Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

Authors:  Eva Warlich; Johannes Kuehle; Tobias Cantz; Martijn H Brugman; Tobias Maetzig; Melanie Galla; Adam A Filipczyk; Stephan Halle; Hannes Klump; Hans R Schöler; Christopher Baum; Timm Schroeder; Axel Schambach
Journal:  Mol Ther       Date:  2011-02-01       Impact factor: 11.454

6.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

7.  Tumor stem cells: A new approach for tumor therapy (Review).

Authors:  Min Meng; Xin-Han Zhao; Qian Ning; Lei Hou; Guo-Hong Xin; Li-Feng Liu
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

Review 8.  Epigenetics of induced pluripotency, the seven-headed dragon.

Authors:  Ugljesa Djuric; James Ellis
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

Review 9.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.